News

STOCKHOLM, SE / ACCESS Newswire / July 9, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) has signed an agreement with AddSecure Smart Care Oy for the distribution of the medication ...
CHICAGO, IL / ACCESS Newswire / July 9, 2025 / Dr. Anosh Ahmed, a respected Republican figure and founder of the Anosh Supports America First Foundation, has pledged immediate aid to families affected ...
VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...
Design Sets a New 2025 Bar for Healthcare AI TAMPA, FL / ACCESS Newswire / July 8, 2025 / While healthcare AI adoption is frequently hindered by poor design, weak integration, and limited clinician ...
While more than 90% of Americans support organ donation, only 52% of North Carolina's licensed drivers are registered organ, ...
Gut Zoomer provides insights crucial in identifying the root causes of chronic disease and other conditions that impact longevity SANTA CLARA, CA / ACCESS Newswire / July 8, 2025 / Vibrant Wellness, a ...
Modus Therapeutics Holding AB (publ) (“Modus”) today announces that patient enrollment in Part 1 of its ongoing Phase IIa study evaluating sevuparin for the treatment of patients with chronic kidney ...
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Hone Health At-Home Testosterone Test + Telemedicine TRTHone Health is on a mission to provide the best TRT services. It just announced it's taking its ...
First-in-human administration of CPV-104 marks a major step in drug development for the company’s lead compound (Factor H) and in bringing a new medication to patientsFreiburg im Breisgau, Germany, ...
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Eladynos® for the treatment of osteoporosis in postmenopausal women at very high risk of fracture*, through the NHS ...
Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / July 8, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists ...
Expanded offering delivers integrated radiopharmaceutical studies using clinically relevant isotopes and highly characterized PDX tumor models HACKENSACK, NJ / ACCESS Newswire / July 8, 2025 / ...